NCT02395497View on ClinicalTrials.gov

Human Penile Allotransplantation

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2034

Study Completion Date

June 30, 2039

Conditions
AmputationWounds and InjuriesAmputation, TraumaticUrologic Surgical Procedures, MaleAmputation, Traumatic/SurgeryPenis/TransplantationPenis/SurgeryPenis/InjuriesCongenital Anomaly, Male Genitalia
Interventions
BIOLOGICAL

Monoclonal Antibody (Humanized Anti-CD52)

DRUG

Tacrolimus

PROCEDURE

Penile Allotransplantation

Trial Locations (1)

21287

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER